Calidi Biotherapeutics

Calidi Biotherapeutics, Inc. is a clinical-stage company based in San Diego, California, that specializes in immuno-oncology services. Since its incorporation in 2014, the company has focused on developing innovative oncolytic virus-based immunotherapies aimed at treating challenging malignancies. Calidi utilizes a patented allogeneic cell-based delivery system designed to enhance the effectiveness of oncolytic viruses, enabling targeted therapies that provide new treatment options for patients with cancer. Through its advanced stem cell-based platforms, Calidi aims to pioneer the commercialization of these novel therapies, contributing to the evolution of cancer treatment.